Summary The antiproliferative effects of gossypol on human MCF-7 mammary cancer cells and cyclin Dl-transfected HT-1060 human fibrosarcoma cells were investigated by cell cycle analysis and effects on the cell cycle regulatory proteins Rb and cyclin Dl. Flow cytometry of MCF-7 cells at 24 h indicated that 10 gm gossypol inhibited DNA synthesis by producing a G,/S block. Western blot analysis using antihuman Rb antibodies and anti-human cyclin Dl antibodies in MCF-7 cells and high-and low-expression cyclin Dl-transfected fibrosarcoma cells indicated that, after 6 h exposure, gossypol decreased the expression levels of these proteins in a dose-dependent manner. Gossypol also decreased the ratio of phosphorylated to unphosphorylated Rb protein in human mammary cancer and fibrosarcoma cell lines. Gossypol (10 gM) treated also decreased cyclin D1-associated kinase activity on histone Hi used as a substrate in MCF-7 cells. These results suggest that gossypol might suppress growth by modulating the expression of cell cycle regulatory proteins Rb and cyclin Dl and the phosphorylation of Rb protein.
has long been recognized as an anti-fertility agent and, more recently, it has been demonstrated to inhibit the growth of various carcinoma cell lines in vitro (Floridi et al, 1983; Joseph et al, 1983; Haspel et al, 1984 ; Tuszynski and Cossu, 1984; Band et al, 1989; Benz et al, 1990; Jaroszewski et al, 1990 ) and in vivo (Wu et al, 1989; Rao et al, 1985) including oestrogen-sensitive (MCF-7 and MCF-7 Adr) and -insensitive (MDA-MB-231) human mammary cancer cells (Hu et al, 1993; Gilbert et al, 1995) . Clinically, gossypol has been efficacious in the treatment of metastatic adrenal cancer (Flack et al, 1993) , holding promise as an anti-tumour agent.
Numerous biochemical studies have been conducted to elucidate the mechanisms by which gossypol exerts its antiproliferative effects (Rosenberg et al, 1986; Adlakha et al, 1989) . Data are limited and understanding of gossypol's influence on cell cycle control of DNA synthesis and antimitogenic activity is incomplete (Wang and Rao, 1984 ; Thomas et al, 1991) . We wished to determine whether gossypol could induce changes in the expression of cell cycle regulatory proteins, such as the retinoblastoma (Rb) gene product (pRb) and cyclin Dl, in human mammary cancer cells, a tumour type associated with mutation of the Rb gene T'Ang et al, 1988; Varley et al, 1989) as well as overexpression and amplification of cyclin Dl (Buckley et al, 1993; Keyomarsi and Pardee, 1993) . In addition, we studied the influence of gossypol on the phosphorylation of Rb protein. For this purpose we used the human mammary cancer cell line MCF-7, which has oestrogen and progesterone receptors, as do certain human cancers in vivo. Additionally, we wished to study gossypol effects on cell cycle phases in MCF-7 cells. Furthermore, to determine the importance of gossypol inhibition on cyclin DI and Rb protein in its antiproliferative effect, we performed similar studies in human fibrosarcoma cells that overexpress cyclin Dl.
MATERIALS AND METHODS Cell culture
MCF-7 human mammary cancer cells and HT 1060 human fibrosarcoma cells were obtained from the American Type Culture Collection (Rockville, MD, USA).
The HT 1080 cells were maintained in log-phase growth in RPMI medium (Media Preparation Core Facility, Sloan-Kettering Institute) supplemented with 10% FCS (Sigma, St Louis, MO, USA). Transfection of a cyclin DI -expressing plasmid was carried out as previously described (Hochhauser et al, 1996) . Relative expression of cyclin Dl mRNA ratios were 14.4 and 0.48 for the high-and low-expression clones, whereas the comparable cyclin Dl expression ratios were 2.88 and 0.9 as compared with the vector-only-transfected control (Hochhauser et al, 1996) .
Racemic gossypol (Sigma) dissolved in dimethylsulphoxide (DMSO) was added to culture medium samples [Dulbecco's modified Eagle medium (DMEM) (Ham's F12/DME, 2:1, v/v) supplemented with 10% fetal calf serum (FCS), 100 ig ml-' streptomycin, 100 U ml-' penicillin and 2 mm glutamine] and incubated at 37°C in a 5% carbon dioxide/95% air atmosphere for 24 h. In order to minimize gossypol oxidation, reduced glutathione was added to the culture medium (2 mM).
[3H]Thymidine incorporation assay MCF-7 human mammary cancer and HT 1080 human fibrosarcoma cells were inoculated individually in six-well dishes (9.6 cm2 area) in a volume of 2 ml of DMEM supplemented with 10% FCS at a density of 5 x 104 cells per well. After 2 days, gossypol dissolved in DMSO was added to the culture medium. Incubations with gossypol were carried out for various time intervals at 37°C. Before cell harvest, cells were labelled with [3H]thymidine (20 gCi per well) at 37°C for 3 h and washed three times with Hanks' balanced salt solution (HBSS). Cells were solubilized with 0.5% SDS (w/v) at 37°C for 10 min.
To cell lysates, 10% trichloroacetic acid (TCA) (v/v) was added and incubation continued for 30 min on ice. TCA-precipitated samples were filtered using glass fibre filters (Enzo Diagnostics, Syosset, NY, USA) to separate bound and free radioactivity. Filters were then washed three times with ice-cold 10% TCA (v/v). Radioactivity retained on the filters was determined with a scintillation counter. On the following day the nitrocellulose membranes were washed with 1 x TBS for 20 min and incubated with horseradish peroxidase conjugated either with anti-mouse or anti-rabbit IgG for 1 h at room temperature. Secondary antibody was at a concentration of 1:1000 dilution. After reaction, membranes were washed and developed by chemiluminescence (ECL) (Amersham) (Whitehead et al, 1979) , and exposed to XAR5 film (Kodak).
The monoclonal antibody for pRB was obtained from Pharmingen (cat. no. 14001A). Cell extracts were prepared as in the manufacturer's instructions (Santa Cruz Biotechnology). Protein concentrations were estimated by the Bradford assay as described. Immunoblots were prepared as in the manufacturer's instructions (Santa Cruz Biotechnology). Total protein (100 jg) was loaded for each sample after addition of SDS polyacrylamide sample buffer and boiling for 5 min. Protein loading was visualized by Poinceau staining. Samples were electrophoresed on 7% polyacrylamide/SDS gels. Nitrocellulose membranes (Optitran, Schleicher & Schuell) were incubated with the enhanced chemiluminescence system as described in the manufacturer's instructions (Amersham) and exposed to film. In vitro cyclin Dl kinase assay MCF-7 cells (106 cells per 100 mm dish) treated with or without 10 jM gossypol for 24 h were lysed in 0.3 ml of lysis buffer containing 50 mM Tris (pH 8.0), 120 mm sodium chloride, 50 mm sodium fluoride, 0.1 mm sodium vanadate, 2 mm EDTA, 10 jig ml-each of chymostatin, leupeptin, antipain and pepstatin A; 2 jig ml 4-(2-aminoethyl)benzenesulphonyl fluoride and 0.4% Nonidet P-40. The extracts were clarified by centrifugation at 14 000 r.p.m. for 15 min at 4°C. Lysates were incubated for 1.5 h at 4°C with polyclonal antibody against cyclin Dl. Immune complexes were collected using 20 jil of protein A-Sepharose and washed three times with 1 ml of lysis buffer and once with 1 ml of kinase buffer containing 20 mM Tris (pH 7.5)-10 mm magnesium chloride. Histone HI kinase assay was performed on a bead. The British Journal of Cancer (1997) 76(1) 
RESULTS Antiproliferation
As in other systems, the antiproliferative effects of gossypol have been established with [3H]thymidine uptake and cell stage analyses (Wang and Rowe, 1984; Thomas et al, 1991) . We employed these techniques to validate their applicability to MCF-7 human mammary cancer cells and HTl080 fibrosarcoma cells transfected with cyclin Dl.
We assessed the antiproliferative effects of gossypol by counting the number of viable MCF-7 cells (trypan blue exclusion). Gossypol inhibited growth of MCF-7 human mammary cancer cells in a dose-dependent manner with an estimated IC50 of 3 gM over a 3-day incubation period (data not shown). In addition, the dose dependence and the kinetics of inhibition of [3H]thymidine incorporation into DNA were determined. In the MCF-7 cells the pattern of anti-mitogenesis was dose and time related (data not shown). Six hours after the addition of the drug, all gossypol concentrations produced a significant decrease in thymidine uptake, with 10 gM gossypol causing a 50% reduction in thymidine incorporation. Gossypol concentrations of 7.5 and 5 JIM attained 50% reduction in thymidine incorporation after 11 and 16 h respectively. with disappearance of the more slowly migrating band (Figure 3 ). This is consistent with the slower moving band representing phosphorylated Rb protein and the more rapidly moving band being non-phosphorylated Rb.
Whereas the growth-suppressing activity of Rb is regulated by its phosphorylation state, which in turn is regulated by cyclin D1/Cdk4 complexes in other mammalian cells, it was of interest to determine whether gossypol also affects the expression of these proteins in MCF-7 cells. We have found that gossypol also decreased cyclin Dl protein levels in MCF-7 cells in a dosedependent manner (Figure 4 ). The effect of 10 JM gossypol on cyclin Dl was apparent as early as 6 h and almost completely at 16 h ( Figure 5 ). Gossypol (10 JM) decreased cyclin DI-associated kinase activity on histone Hi as a substrate in MCF-7 cells after 24 h of treatment (Figure 6) . Although gossypol at the highest concentration tested (10 JM) produced a 50% antiproliferative effect, gossypol (10 JM) over 24 h had no effect on expression of Cdk4, actin, vinculin or p21 (data not shown). Thus, the effects on cyclin D, Rb and histone Hl kinase would appear not to be an experimental artifact due to cell loss.
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DISCUSSION
Numerous biochemical effects of gossypol have been described, such as uncoupling of oxidative phosphorylation and inhibition of many membrane-associated enzymes (Lee et al, 1982; Bugeja et al, 1988; Nakamura et al, 1988) . Indeed, in our earlier studies of the effects of gossypol on human erythrocyte function, we noted that 10 gM gossypol inhibited inorganic anion exchange and interaction with band 3 without effect on eight other membrane functions (Haspel et al, 1985) . However, it has been difficult to determine the specific site and mechanism of action or link these actions to the tumoricidal effects of gossypol in vitro.
To elucidate other molecular mechanisms that could mediate gossypol's antiproliferative effects (data not shown), we first assessed the overall effect of gossypol on the cell cycle of MCF-7 cells. Our data on cell cycle analysis in non-synchronized populations of MCF-7 cells suggest that gossypol arrests cells in G1/S, in agreement with other studies demonstrating that gossypol inhibits growth in vitro by reducing the growth fraction (Wang and Rao, 1984; Thomas et al, 1991) . As gossypol specifically acts in the GI phase to prevent cells from entering S phase, it was of interest to determine whether gossypol could affect cell cycle-regulated proteins, in particular Rb and cyclin Dl proteins, which are critical for G. to S progression. Rb protein is known to be crucially involved in cellular growth regulation and exists as hypo-and hyperphosphorylated forms, its phosphorylation status being highly cell cycle phase dependent (Cooper & Whyte, 1989) . The unphosphorylated form of the Rb protein is found in quiescent and GI phase cells, restricting G, to S progression by an interaction with the E2F transcription factor (Chellappan et al, 1991) . It is a target of complex formation with several oncoproteins, e.g. E7, known to have an immortalizing effect on infected cells (Green, 1989) , an inactivation mechanism functionally similar to the Rb protein phosphorylation or to its loss by gene mutation or deletion, resulting in unregulated cell proliferation. Introduction of the Rb gene into cancer cells lacking a functional endogenous Rb gene has been found to reverse their transformed phenotype and tumorigenicity, a finding providing conclusive evidence of its tumoursuppressing activity (Huang et al, 1988) .
We found that the expression levels of the Rb and pRb proteins decreased in response to gossypol treatment in MCF-7 cells, a cancer cell line that predominantly expresses the phosphorylated form of the Rb protein . In SDS-PAGE gels in which non-phosphorylated was separated from phosphorylated Rb protein, we noted a greater decrease in the more slowly migrating pRb band. This is consistent with a decrease in phosphorylated Rb due to inhibition of phosphorylation. There may also be inhibition of Rb protein expression after gossypol treatment (Figure 3 ). Whether gossypol affects Rb protein expression at the transcriptional and/or translational as well as post-translational level remains to be determined.
We have also demonstrated that gossypol decreases the expression of cyclin DI protein in MCF-7 cells. Cyclin DI is considered to be essential for progression through the G, phase of the cell cycle in a variety of human normal and tumour cells (Baldin et al, 1993; Lukas et al, 1994) . It has been shown that cyclin Dl associates with Cdk4 during the GI phase in synchronized cells (Kato et al, 1993) . The cyclin D1-Cdk4 complex assembled in a subcellular assay or as a result of the coexpression of cyclin DI and Cdk4 in intact insect cells phosphorylates the Rb protein in vitro (Matsushime et al, 1992; Kato et al, 1993) . It has been suggested, therefore, that cyclin DI functions by inactivating the inhibitory effects of the Rb protein on cell cycle progression (Jiang et al, 1993) . Gossypol treatment did not affect Cdk4 levels but inhibited cyclin DI expression. This may account for the observed reduction in cyclin DI-associated kinase activity on histone HI in MCF-7 cells ( Figure 6 ). Gossypol, through its ability to decrease the concentration of cyclin DI may effectively decrease the amount of phosphorylated Rb and, thus, arrest cells in GI. The correspondence of the gossypol effects on both Rb and cyclin D1 as reflected in similar kinetics ( Figure 5 ) and concentration ( Figures  3 and 4) is consistent with cyclic Dl in association with Cdk4 catalysing the phosphorylation of Rb. The effects of gossypol on other cyclins and Cdks required for entry into S phase, such as cyclin E, Cdk2 and Cdk5, remain to be studied. To confirm the role of cyclin DI in mediating the effect of gossypol, we exposed HT1080 cells transfected with cyclin DI to gossypol. These cells have been demonstrated to have increased phosphorylation of pRb. Gossypol has a lesser effect on proliferation in transfectants with high cyclin Dl. Furthermore, although these cells also show a reduction in pRb expression after exposure to gossypol, phosphorylated pRb is detectable in cells with high cyclin Dl. Recently, small protein inhibitors of cyclin-Cdk (Ckis) have been shown to play an important role in regulating the activity of cyclin-dependent kinases. In mammals, pI6, p21 and p27 have been shown to inhibit cyclin D1-Cdk4 (Toyoshima and Hunter,
